| Literature DB >> 31763998 |
Andrew D Hughes1,2, Daqiang Zhao1,3,4, Hehua Dai1,3, Khodor I Abou-Daya1,3, Roger Tieu1,5, Rayan Rammal6, Amanda L Williams1,3, Douglas P Landsittel1,7, Warren D Shlomchik1,8,9, Adrian E Morelli1,3,9, Martin H Oberbarnscheidt1,3,9, Fadi G Lakkis1,3,5,9.
Abstract
Activation of host T cells that mediate allograft rejection is a 2-step process. The first occurs in secondary lymphoid organs where T cells encounter alloantigens presented by host DCs and differentiate to effectors. Antigen presentation at these sites occurs principally via transfer of intact, donor MHC-peptide complexes from graft cells to host DCs (cross-dressing) or by uptake and processing of donor antigens into allopeptides bound to self-MHC molecules (indirect presentation). The second step takes place in the graft, where effector T cells reengage with host DCs before causing rejection. How host DCs present alloantigens to T cells in the graft is not known. Using mouse islet and kidney transplantation models, imaging cytometry, and 2-photon intravital microscopy, we demonstrate extensive cross-dressing of intragraft host DCs with donor MHC-peptide complexes that occurred early after transplantation, whereas host DCs presenting donor antigen via the indirect pathway were rare. Cross-dressed DCs stably engaged TCR-transgenic effector CD8+ T cells that recognized donor antigen and were sufficient for sustaining acute rejection. In the chronic kidney rejection model, cross-dressing declined over time but was still conspicuous 8 weeks after transplantation. We conclude that cross-dressing of host DCs with donor MHC molecules is a major antigen presentation pathway driving effector T cell responses within allografts.Entities:
Keywords: Adaptive immunity; Antigen presentation; Immunology; MHC class 1; Transplantation
Mesh:
Year: 2020 PMID: 31763998 PMCID: PMC6934226 DOI: 10.1172/JCI125773
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808